Zobrazeno 1 - 9
of 9
pro vyhledávání: '"N. V. Kononova"'
Publikováno v:
Бюллетень сибирской медицины, Vol 18, Iss 3, Pp 107-115 (2019)
Purpose. Increasing of treatment efficiency for patients with acute pancreatitis by improving objective means of determining the severity of acute pancreatitis.Materials and method. The study was based on a retrospective analysis of 130 cases of acut
Externí odkaz:
https://doaj.org/article/42075d036257403ca7eeb1619662d6b1
Publikováno v:
Informatics and Cybernetics in Intelligent Systems ISBN: 9783030774479
This paper reviews research on the design of a multi-loop control systems for a group of technological processes under incomplete information. In this case the information about functional dependence between the various process parameters is unknown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0516d8752f9d7d43ef75b7f01df1d86
https://doi.org/10.1007/978-3-030-77448-6_1
https://doi.org/10.1007/978-3-030-77448-6_1
Publikováno v:
Russian Journal of Bioorganic Chemistry. 41:357-363
A new solubilization method of recombinant interferon beta-1b (IFNβ-1b) from the inclusion bodies was developed. This method allows to extract the target protein selectively in the solutions of different alcohols, such as ethanol, propanol and isopr
Autor:
A. M. Zhuravko, S. V. Minaev, N. V. Kononova, N. N. Pankeev, V. A. Mart’yanov, A. V. Yakovlev, A. I. Bobruskin
Publikováno v:
Russian Journal of Bioorganic Chemistry. 40:507-515
We developed a unified process platform for two recombinant human GCSF medicines--one with the non-prolonged and the other with prolonged action. This unified technology led to a simpler and cheaper production while introduction of the additional peg
Autor:
A. M. Shuster, I. A. Puchkov, A. I. Bobruskin, N. V. Kononova, D. I. Bairamashvili, V. A. Mart’yanov
Publikováno v:
Russian Journal of Bioorganic Chemistry. 38:479-487
In order to create an active pharmaceutical substance of the drug with prolonged action the modification of recombinant human granulocyte colony-stimulating factor GCSF (filgrastim) with polyethylene glycol (PEG, M 21.5 kDa) was conducted. A method f
Autor:
N. V. Kononova, V. A. Mart’yanov, A. A. Zinchenko, A. A. Vainson, T. D. Melikhova, E. V. Sveshnikova, T. I. Kostromina, A. I. Bobruskin, A. V. Demin, D. I. Bairamashvili, A. M. Shuster
Publikováno v:
Applied Biochemistry and Microbiology. 46:726-732
Technology of industrial production of an active pharmaceutical substance (APS) of the recombinant human granulocyte colony-stimulating factor (rhG-CSF) involved the use of a highly productive E. coli strain capable of biosynthesis of rhG-CSF in the
Publikováno v:
Bioorganicheskaia khimiia. 41(4)
A new solubilization method of recombinant interferon beta-1b (IFNβ-1b) from the inclusion bodies was developed. This method allows to extract the target protein selectively in the solutions of different alcohols, such as ethanol, propanol and isopr
Autor:
N V, Kononova, A V, Iakovlev, A M, Zhuravko, N N, Pankeev, S V, Minaev, A I, Bobruskin, V A, Mart'ianov
Publikováno v:
Bioorganicheskaia khimiia. 40(5)
We developed a unified process platform for two recombinant human GCSF medicines--one with the non-prolonged and the other with prolonged action. This unified technology led to a simpler and cheaper production while introduction of the additional peg
Autor:
N. V. Kononova, A. S. Arseniev, E. V. Grishin, D. N. Bocharov, S. V. Sukhanov, T. A. Balashova, Pluzhnikov Ka
Publikováno v:
Russian Journal of Bioorganic Chemistry. 32:478-484
The venom of South American ant Paraponera clavata and its low-molecular-mass fraction were shown to possess insectotoxic and pore-forming activities. A number of glycophospholipid components were isolated from this ant venom by means of gel filtrati